Clinical value of CD24 expression in retinoblastoma

Jia Li1, Changqing Li, Hongfeng Yuan

  • 1Department of Ophthalmology, Research Institute of Surgery and Daping Hospital, Third Military Medical University, Chongqing, China.

Abstract

Insights

CD24 protein is highly expressed in high-risk retinoblastoma tumors, unlike low-risk ones. This finding suggests CD24 may play a role in retinoblastoma progression and warrants further investigation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Ophthalmology

Background:

  • CD24 protein expression is implicated in various human cancers, influencing tumor growth and metastasis.
  • While CD24's role is known in other malignancies, its expression and function in retinoblastoma remain unstudied.
  • Understanding CD24 in retinoblastoma is crucial for elucidating tumor progression mechanisms.

Purpose of the Study:

  • To investigate the expression profile of CD24 in retinoblastoma tumor samples.
  • To correlate CD24 protein levels with clinicopathological parameters in retinoblastoma patients.

Main Methods:

  • Immunohistochemistry was used to detect CD24 expression in archival retinoblastoma paraffin sections.
  • Western blotting was employed to validate the immunohistochemistry findings.
  • Expression levels were correlated with clinicopathological features.

Main Results:

  • CD24 immunoreactivity was detected in 72% of retinoblastoma specimens (36/50).
  • CD24 expression was significantly higher in high-risk retinoblastoma tumors (93.3%, 14/15) compared to low-risk tumors (62.9%, 22/35).
  • A statistically significant correlation (P < 0.05) was found between increased CD24 expression and high-risk retinoblastoma.

Conclusions:

  • This study establishes the first correlation between CD24 expression and histopathology in human retinoblastoma.
  • Elevated CD24 expression is associated with high-risk retinoblastoma, suggesting a potential role in disease progression.
  • Further functional studies are necessary to fully elucidate the role of CD24 in retinoblastoma pathogenesis.